Site of Isotretinoin Metabolism
Isotretinoin is metabolized primarily in the liver through hepatic cytochrome P450 enzymes, specifically CYP2C8, CYP2C9, CYP3A4, and CYP2B6. 1
Primary Metabolic Pathway
- Hepatic metabolism is the principal site where isotretinoin undergoes biotransformation after oral absorption 1
- The liver converts isotretinoin through oxidation and glucuronidation pathways 2
- In vitro studies definitively identify the primary P450 isoforms involved in isotretinoin metabolism as CYP2C8, CYP2C9, CYP3A4, and 2B6 1
Major Metabolites Formed
Following hepatic metabolism, at least three major metabolites are identified in human plasma:
- 4-oxo-isotretinoin (the predominant metabolite, with exposure approximately 3.4 times higher than parent isotretinoin at steady-state) 1
- Retinoic acid (tretinoin) - formed through reversible geometric isomerization 1
- 4-oxo-retinoic acid (4-oxo-tretinoin) - formed when 4-oxo-isotretinoin undergoes geometric isomerization 1
Secondary Metabolic Processing
- Isotretinoin and its metabolites undergo further hepatic metabolism into conjugates (primarily glucuronides) before excretion 1
- Biliary excretion of isotretinoin glucuronide represents a major metabolic pathway, accounting for 34.8-37.9% of the administered dose in animal studies 3
- The conjugated metabolites are ultimately excreted in feces and urine in relatively equal amounts (total of 65% to 83%) 1
Clinical Implications
- Hepatic metabolism necessitates liver function test monitoring during isotretinoin treatment, as abnormal liver function tests occur in 0.8% to 10.4% of patients 4
- The hepatic cytochrome P450 system involvement means isotretinoin can alter transcription of multiple enzymes and transporters, though clinical drug-drug interactions require individual evaluation 5